Work

High-throughput Human Cell Reprogramming through Substrate and Microfluidics Integration

Year: 2014
Type: article
Abstract: Human cells and tissues are key systems to study human biology and physiology, and to develop new strategies and targeting drugs for human diseases. Since the study and testing on human beings may not be acceptable due to exposure to risks and practical and ethical concerns, in vitro strategies are of paramount importance to rely on human organism and avoid non-fully predictive animal models. The demand of research in clinical and industrial fields for effective, representative and affordable strategies is undoubtedly increasing. Conventional cell culture systems and drug discovery are normally performed in vessels with a characteristic dimension in the order of centimeters. Nutrients are delivered to cells through liquid media containing balanced saline buffers and oligo-elements. A reasonable amount of medium is necessary to homogeneously cover a cell layer and must exchanged with fresh media to maintain a proper amount of available nutrients and remove released waste products. Many studies and applications require expensive reagents and are subjected to limited data throughput. The discovery of reprogramming process by 2012 Nobel Prize Yamanaka opened breakthrough new perspective on research and clinical applications. Basically, from a patient’s skin biopsy it is now possible to derive induced pluripotent stem cells (iPSC) and to obtain new tissues for an ad hoc self-repair. So far, human iPSC (hiPSC) have not been applied to clinics due to some unexplored aspects on their derivation, non clinical-grade methods and the significative cost of hiPSC derivation per patient. The down-scale of reprogramming process could provide an unique opportunity to derive cost-effective hiPSC and obtain valuable human in vitro tissues. The aim of this thesis is the development of a comprehensive platform for the reprogramming of human cells at the microscale. To this end, we focused on the development of cell microenvironment which is composed by both soluble and solid components. During this thesis, synthetic and biodegradable hydrogels were developed. The large-scale production of mechanically-tunable poly-acrylamide-based substrates were fundamental to reveal the interaction occurring between substrate stiffness and cell behavior and fate. Engineering of biodegradable hydrogels has revealed the potential to develop in vitro functional tissues and to integrate them at a later stage in patients. Chemical modifications were transferred to topological substrate control and in turn in microfluidic platforms. Microfluidic chip environment and management was designed in order to allow long-term adhesion, culture and biologically relevant cell behaviors. Adhesion proteins fundamental for cell attachment and growth were modified and integrated with the micronized substrates. Since medium for microfluidic cell culture relies on perfusion, continuous or periodic flow could be applied. Thus, we studied the management of media delivery in order to determine the best strategy for long-term cell cultures. The achievements obtained with both substrate and microfluidic cell culture development was applied to the generation of a new platform for hiPSC derivation, differentiation and testing at the microscale. For the first time, it is possible to obtain human iPSC clones in microfluidics with a remarked reduction of minimum requirements (materials, reagents, overall expenses). The production of cost effective hiPSC can lead to a mass production of characterized and functional tissues that can be either integrated in 3D developed constructs and serve as valuable tissue source derivation for drug development. Our platform opens new perspectives in studying and treating both abundant and rare diseases involving both scientists and entrepreneurs
Language: English
Open Access status: green
OpenAlex ID: W32266094
FWCI:
Cites: 299
Cited by:
Related to: 10